Inside Precision Medicine June 5, 2023
After decades of research, cell and gene therapies are gaining traction in the biotech industry. Here are five investor-favored private startups with products already in clinical development.
While conventional medications are often effective at controlling symptoms or modifying a disease, there are many conditions where their benefits are limited, such as rare genetic diseases.
One way to bridge the gap is with cell and gene therapies. Cell therapies involve giving patients engineered cells as “living drugs,” which can be sourced from patients themselves (autologous cells) or from healthy donors (allogeneic cells). Depending on the type of therapy, the infused cells could fight cancer or even reverse organ damage by rebuilding damaged tissues.
Gene therapies, on the...
Today's Sponsors
Today's Sponsor